119. Guideline Series: Pulmonary Embolism

The 2026 multi-society clinical practice guidelines for acute pulmonary embolism (PE) establish a comprehensive A-E risk stratification framework, replacing traditional hemodynamic labels with a clinical continuum that better guides management. Dr. Mark Creager, lead author and cardiovascular medicine specialist, highlights that this system improves clinical decision-making by categorizing patients from subclinical findings to refractory cardiopulmonary failure. The guidelines now prioritize low-molecular-weight heparin as the standard for initial anticoagulation due to its superior kinetics and safety profile. Furthermore, the document emphasizes the role of multidisciplinary Pulmonary Embolism Response Teams (PERT) in coordinating care for high-risk patients and underscores the necessity of structured follow-up within one week of discharge. While advanced therapies like catheter-directed interventions are considered for severe cases, current recommendations remain cautious, awaiting further clinical trial outcomes to solidify long-term mortality benefits.